ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 20.98 USD -4.9% Market Closed
Market Cap: 3.5B USD
Have any thoughts about
ACADIA Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 27.54 USD with a low forecast of 15.15 USD and a high forecast of 38.85 USD.

Lowest
Price Target
15.15 USD
28% Downside
Average
Price Target
27.54 USD
31% Upside
Highest
Price Target
38.85 USD
85% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
33% Upside
PRQR
ProQR Therapeutics NV
296% Upside
SKYE
Skye Bioscience Inc
341% Upside
1952
Everest Medicines Ltd
20% Downside
RNA
Avidity Biosciences Inc
117% Upside
CSL
CSL Ltd
33% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
12% Downside
IMAB
I-Mab
159% Upside

Revenue
Forecast

Revenue Estimate
ACADIA Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for ACADIA Pharmaceuticals Inc's revenue is 60%. The projected CAGR for the next 3 years is 13%.

60%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ACADIA Pharmaceuticals Inc

The compound annual growth rate of ACADIA Pharmaceuticals Inc's operating income for the next 3 years is 45%.

N/A
Past Growth
45%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
ACADIA Pharmaceuticals Inc

The compound annual growth rate of ACADIA Pharmaceuticals Inc's net income for the next 3 years is 6%.

N/A
Past Growth
6%
Estimated Growth
Estimates Accuracy
-29%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACAD's stock price target?
Price Target
27.54 USD

According to Wall Street analysts, the average 1-year price target for ACAD is 27.54 USD with a low forecast of 15.15 USD and a high forecast of 38.85 USD.

What is ACADIA Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
13%

For the last 13 years the compound annual growth rate for ACADIA Pharmaceuticals Inc's revenue is 60%. The projected CAGR for the next 3 years is 13%.

What is ACADIA Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
45%

The compound annual growth rate of ACADIA Pharmaceuticals Inc's operating income for the next 3 years is 45%.

What is ACADIA Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
6%

The compound annual growth rate of ACADIA Pharmaceuticals Inc's net income for the next 3 years is 6%.

Back to Top